Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the comparative effectiveness of Risperdal
(risperidone) or bupropion ER (extended release) combined with a SSRI medication and to test
the relative safety of the combinations.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center